Academics & Research

Immunology, Inflammation, & Infectious Disease (3i) Initiative

COVID-19 Funding Opportunities

Below is a curated list of current COVID-19 related funding opportunities and Notices/Announcements for a broad range of research topics including non-STEM disciplines. 

Last Updated - October 27th - 3:15PM


 NEW funding opportunities since October 27th are:

                              1. HHS - Monitoring Cause Specific School Absenteeism with COVID & the Flu
                              2. Smoke Free World 
                              3. Collective Future Fund 

Listings are categorized in the following groups:


National Institutes Of Health

IC

Opportunity Title 

Deadline

NIAID 

Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)

(R21 Clinical Trial Not Allowed) 

April 30, 2021 
NIAID 

Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)

(R01 Clinical Trial Not Allowed) 

April 30, 2021
OD 

NIH Director's Emergency Tranformative Research Awards 

August 30, 2020 
NIH / Multiple 

Community Interventions to Address the Consequences of COVID-19 Pandemic among Health Disparity and Vulnerable Populations

Opens July 28, 2020 
Back to top

Federal Supplements

Agency/IC

Supplement Title 

Deadline

NIH / NIDCR / ORWH 

NOSI: Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCR 

November 2, 2020 
NCATS 

NOSI: New Administrative Supplemet Applications to UL1 and U24 CTSA Awards to Address COVID-19 Public Health Need 

Rolling Basis until November 10, 2020 
NCATS

NOSI: Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Traslational Science Award (CTSA) Program Awards to Address COVID-19 Public Health Needs 

November 11, 2020 

Department of Veterans Affairs / Clinical Science Research and Development Service

Supplemental funding Opportunity for Research Related to COVID-19  Applications will continue to be accepted on a rolling basis
NIA / NIAID / NIDDK / NIDA / NIMH / NIEHS / NICHD / NIAAA / NIBIB 

Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement -  Clinical Trial Optional)

Various Dates
NIGMS 

NOSI Regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Caustive Virus SARS-CoV2 

Rolling basis through February 5, 2021
Office of Behavioral and Social Sciences Research (OBSSR)

NOSI: Availability of Administrative Supplements and Urgent Competitive Revisions for Reseach on COVID-19 and the Behavioral and Social Sciences 

Rolling Basis through March 31, 2021
National Institute of Mental Health (NIMH) 

NOSI:Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on COVID-19 

April 15, 2021 
NIMH / NIA / NIAA / NIMHD / ODP

NOSI: Regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus 

April 16, 2021
NIAAA

NOSI: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the mission of NIAAA

April 16, 2021
Office of Diesease Prevention

Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities

May 1, 2021
National Institute on Minority Health and Health Disparities (NIMHD) 

NOSI: Competitive and Administrative Supplements for the Impact of COVID-19 on Minority Health and Health Disparities

May 1, 2021 
National Institute on Aging and National Institute of Mental Health 

Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)

May 1, 2021
HHS / NIH / NCATS 

NOSI: Availability of Administrative Supplements for Tissue Chips Research on COVID-19 

January 25, 2022 
NIDCD

Notice of Eligibility Change for NIDCD Urgent Competitive Revisions and Administrative Supplements for Research on COVID-19 

No Due Date
Back to top

Other Federal 

Agency/Department

Opportunity Title

Deadline

NIH   Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) Research Training Program (U2RClinical Trial Optional) Opens October 23, 2020 ; Closed November 24, 2020
WorkSafe BC

2020 Specific Priorities - Impacts of COVID-19 - Request for Proposals

October 31, 2020
HHS / ASPR Office of Resource Management 

BARDA / BAA - Solicitation 

Rolling Basis until October 31, 2020
NIH / National Heart, Lung and Blood Institute (NHLBI) NOSI: Highlighting the Urgent Need for Research on Coronavirus 

Rolling deadline through October 5, 2020 

Collective Future Fund  Survivor Safety and Securing Democratic Futures Fund 

November 9, 2020 

 National Institute of Biomedical Imaging and Bioengineering (NIBIB) 

NOSI: Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for COVID-19

Expires on November 10, 2020
NIDDK 

Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK

Opens November 16, 2020 

Due December 16, 2020

Smoke Free World

COVID-19, Smoking, and Nicotine Research

December 15, 2020 

HHS / CDC

Monitoring Cause-specific School Absenteeism for Estimating Community-wide Influenza and SARS-CoV-2 Transmission  

December 18, 2020 

BioPama

Rapid Response Grants 2020  

December 31, 2020

National Council on Disabilities  Pre-Solicitation for 2021 Progress Report - COVID-19's Broadscale Impact on People with Disabilities No Date Listed
NIH POCTRN

Fast-Track Program for COVID-19 Test Development and Distribution Innovative Technologies to Increase U.S. Capacity for COVID-19 Testing 

No Date Listed 
NSF

Dear Colleague Letter: Sentinel Cells for Surveillance and Response to Emergent Infectious Disease

No Date Listed
The Lung Ambition Alliance

Junior Faculty Research Grants for the Study of Lung Cancer and COVID-19 Infection 

No Date Listed
HSR&D HSR&D Rapid Response Projects for Time-Sensitive Topics: COVID-19 

Applications will continue to be accepted on a rolling basis after the initial 4/6/20 deadline. 

PCORI

Funding Opportunity for COVID-19-Related Enhancements to Existing PCORI-Funded Dissemination and Implementation Awards

Rolling Basis

National Center for Advancing Translational Sciences (NCATS) 

Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need

Multiple depending on Mechanism 

PCORI

Funding Opportunity for COVID-19-Related Enhancements to Existing PCORI-Funded Research Projects 

Rolling Basis

NIEHS 

NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) 

Rolling Basis 

Bread & Roses Community Fund 

Solidarity Fund for COVID-19 Organizing 

Rolling Basis 

XSEDE (NSF)

COVID-19 HPC Consortium 

None

National Council on Disabilities 

Pre-Solicitation for 2021 Progress Report - COVID-19's Broadscale Impact on People with Disabilities

No Date Listed  

DoD / MCDC 

Solicitation 

Ongoing 

HHS - NIA 

NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required)

Rolling Deadlines until February 1, 2021  

NIA

NIA Multi-Site COVID-19 Related Clinical Tiral Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations 

Rolling Basis until February 2, 2021

HHS - CDC

Emerging Infections Network - Research for Preventing, Detecting, and Managing Travelers who Acquire Infectious Diseases Abroad

February 9, 2021

NIAID

NOSI: Regarding the Availibility of Emergency Competitive Revisions for Research on SARS-Cov-2 and COVID-19 

March 25, 2021

NIDA 

Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 Novel Coronavirus (2019-nCoV, also known as COVID-19)

March 31, 2021

Department of State - Office of the Secretary 

COVID-19 Private Sector Engagement & Partnership Fund 

May 28, 2021

Department of State

2020 TIP Office Annual Program Statement to Address the Impacts of COVID-19

August 5, 2021

NIH / National Center for Advancing Translational Sciences (NCATS)

Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus Public Health Need 

Multiple Depending on Mechanism 
NCI

RFP: Serological Sciences Network Capactiy Building Centers 

No Due Date Listed 
Back to top

 Foundation/Private 

Foundation Grant Support: U of U Health’s Office of Advancement has an office of Foundation Relations that can help faculty with strategic approaches to private foundations. Faculty and staff are encouraged to reach out to Lynn Wong, Director of Foundation Relations (or through your area development officer) with any questions or to discuss an opportunity prior to approaching a funder. Lynn may be reached at 801-587-1066 or lynn.wong@hsc.utah.edu.

Funder

Opportunity Title

Deadline

Ferring Pharmaceuticals  Ferring COVID-19 Investigational Grants Applications accepted through October 31, 2020 
Argonne National Laboratory 

Expedited, Rapid Access Call for COVID-19 Research

No Date Listed 
LifeArc 

COVID-19 Therapeutics

No Due Date Listed
Biogen Foundation 

COVID-19 Response 

Accepting Applications 
Bloomberg Philanthropies

COVID-19 Global Response Initiative

Continuous Submission
Cisco - Research & Open Innovation 

Pandemic / COVID-19 Science, Technology and Social Impact 

No Date Listed 
COVID-19 Early Treatment Fund (CETF) 

Funding for Outpatient Trials 

Currently Accepting Applications 
Draper Richards Kaplan Foundation 

COVID-19 Funding: Coronavirus Urgent Response Initiative (CURI) 

Unspecified 
Fast Grants 

Fast Funding for COVID-19 Science 

Applications are Currently Paused 
Ginkgo Bioworks 

Access to Platform for Partner COVID-19 Projects

No Date Posted 
Innovations for Poverty Action 

Peace & Recovery Program: COVID-19 Off-Cycle Funding

No Due Date Posted 
Jacob and Valeria Langeloth Foundation 

COVID-19 Rapid Response Fund 

No Date Posted 
Kaggle

COVID-19 Open Research Dataset Challenge (CORD-19)

Open
Merck KGaA (Germany) 

Research Grant for Pandemic Preparedness

Applications accepted on a Rolling Basis 
Mercatus Center 

COVID-19 Response: A Call for Ideas

No Date Listed 
Mozilla Open Source Support Program (MOSS) 

COVID-19 Solutions Fund 

Open 
Novartis

Investigator-Initiated Trials

Ongoing 

NOVO 

Novo REPAIR Impact Fund

Global: dates announced in May 

US: Sept 4 & Oct 11 (non-confidential proposals), Dec 2 (invitation for confidential proposals), Jan 10 (deadline for confidential proposals)

Open Road Alliance 

Direct COVID-19 Response - Charitable Grant  Open

COVID-19 Early Treatment Fund (CETF)  

Covid-19 Early Treatment Fund Rolling
 Back to top

Federal Notices

 

National Institutes of Health

IC

Title

National Heart, Lung, and Blood Institute NEW: ***Notice of NHLBI Participation in NOT-OD-20-097 "Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences"
NEW: ***Notice of Expiration of NOT-HL-20-782 "Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials"
NEW: ***Notice of NHLBI Participation in NOT-OD-20-097 "NOSI regarding Availability of Admin Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences”
NEW: ***Notice of NHLBI Participation in NOT-OD-20-119 "Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations"
NEW: ***Notice of NHLBI Participation in NOT-OD-20-120 "Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations"

 

NEW: ***Notice of NHLBI Participation in NOT-OD-20-121 "Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations"

 NIH

NIH has created a central site for its current guidance – including newly updated guidance on late applications, flexibilities for applicants and recipients, and clinical trials - which can be found at https://grants.nih.gov/grants/natural_disasters/corona-virus.htm.

 

NEW: ***Emergency Awards: Chemosensory Testing as a COVID-19 Screening Too
Notice of Common Funds Participation in "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)"
NIH will be sending regular updates to the research community through the NIH Extramural Nexus newsletter.
NIH FAQs: COVID-19  Flexibilities for Applicants and Recipients
See page update history.
COVID-19 Updates and Funding Opportunities 
Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19
NIH Mobilizes National Innovation Initiative for COVID-19 Diagnostics 
NOI: Publishing a Funding Opportunity Announcement for Community Interventions to Address the Consequences of the COVID-19 Pandemic for Health Disparity and Vulnerable Populations 
NOI: Pubishing a Funding Opportunity Announcement for Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 
NOSI: NIAID Priorities for Biomedical Knowledgebases & Repositories
Notice of Change to Eligible Activity Codes for NOT-NS-20-015 "NOSI: Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Biological Effecs of the 2019 Novel Coronavirus on the Nervous System
NOSI: Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19
NEW: ***NOSI: Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
NEW: ***NOSI: Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
NEW: ***NOSI: Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
NEW: *** NOSI: Regarding the Availability of Urgent Competitive Revisions and Admin Supplements for Research on COVID-19 in Individuals with Down Sydrom for the INCLUDE Project 
NEW: *** Notice of Corrections to RFA-OD-20-013 "EMERGENCY AWARDS: RADx-UP Coordination and Data Collection Center (CDCC)" Budget and Review
NEW: *** NIH-Wide Strategic Plan for COVID-19 Research Now Available

 Multiple 

 Emergency Competitive Revision to Existing NIH Awards - "Emergency Supplements - Clinical Trial Optional" (PA-20-135)

Office of Research on Women's Health 

NEW: ***NOSI: Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations

 Office of the Director

UPDATE to Late Application Policy Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19)

NIH Late Application Policy Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19)
Late Application Policy due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19) 
Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19; and  youtube 
General Frequently Asked Questions (FAQs) - Proposal Submission and Award Management Related to COVID-19
Notice of Intent to Publish Funding Opportunity Announcements for the RADx-UP Initiatives 
NEW: *** Guidance for Applicants Preparing Applications for the Fall 2020 Due Dates During the COVID-19 Pandemic
NEW: ***(NOSI): Availability of Emergency Competitive Revisions for Wastewater Surveillance Research for Public Health Response to Coronavirus Disease 2019 (COVID-19)
NEW: ***(NOSI): Availability of Emergency Competitive Revisions for Chemosensory Testing as a COVID-19 Screening Tool
NEW: ***Notice to Clarify and Correct Eligibility in Notices of Special Interest under the Rapid Acceleration of Diagnostics Underserved Populations (RADx-UP) Program
Fogarty International Center FAQs - Proposal Submission and Award Management Related to COVID-19 
NIAID Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
2020 NIAID Omnibus Broad Agency Announcement
Administrative Supplementals
NEW: *** NIAID Late Application Policy for NIAID-Specific with Due Dates in July and August 
NEW: *** NOSI: Regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to SARS-CoV-2 and COVID-19
NEW: *** Notice of the Early Expiration of NOT-AI-20-034
NEW: *** NOSI: Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Chandidates Against SARS-CoV-2
NIAID / NIGMS  Administrative Supplementals
NINDS  NEW: ***Notice to Extend Eligibility for Submission of Diversity KK22 Applications due to COVID-Related Disruptions
NCATS  NOSI: Clinical and Traslational Science Award (CTSA) Program Applications to Address COVID-19 Public Health Need 
NOSI: Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease 
Notice of Change in Eligibility and Activity Coes for NOT-TR-20-011; NOSI: Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus Public Health Need 
NCI  Notice of Information: Contributing to the Global COID-19 CRISIS Response by Allowing Some NCI-Supported Projects to be Redirected to COVID-19-related Research During the Crisis 
NEW: *** Notice of Clarification to Key Dates for RFA-CA-20-039
Small Business Program Office  COVID-19 Update for Small Business Webinar
NIAMS  NEW: *** Notice of NIAMS Participation in PA-20-135

 

Other Federal

Agency/Department

Title

 CDC - BLRD

Interim Lab Biosafety Guideline for Handling and Processing Specimens Associated with Coronavirus Disease 2019 

 Department of Agriculture

 FAQs and Actions to Respond to COVID-19 

 Department of Defense / Basic Research Office 

FAQs

DoD Coronavirus Website

Department of Education 

Information and Resources for Schools and School Personnel 

Guidance for Interruptions of Study related to COVID-19 

FAQs Regarding the Family Educational Rights and Privacy Act and COVID-19 

Protecting Student's Rights during COVID-19 

Protecting Student's Rights during COVID-19 

Department of Energy 

Office of Science's Guidance on program flexibility for grant applicants and awardees 

Dear Colleague Letter

DOE Resources Supporting Coronavirus Research

Department of Homeland Security 

Crucial Research to Mitigate COVID-19 (Released on March 25th, 2020). 

Department of Justice

DOJ/Office of Justice Programs - Deadline Extension 

 Department of Labor 

COVID-9 and the American Workplace

Resources for Workers and Employees

Department of State 

Novel Coronavirus (COVID-19)

HHS Office of the Assistant Secretary for Preparedness and Response (ASPR) - Public Health Emergency development of new medical countermeasures
Office of the Assistant Secretary for Preparedness and Response (ASPR) - Public Health Emergency
FAQs for Health Centers Regarding Novel Coronavirus (COVID-19)
New Action to Cut Red Tape to Support COVID-19 Response
Center for Disease Control and Prevention (CDC) - CDC Funding Information (as of March 11, 2020) 
Updated a broad agency announcement (BAA) to solicit proposals for advanced development and licensure of COVID-19diagnostics, vaccines, or medicines such as therapeutics or antivirals.
 Medical Countermeasures Task Force  Request a USG CoronaWatch Meeting 
National Institute of Food and Agriculture Extension of Deadlines 
National Aeronautics and Space Administration  NASA Coronavirus Response Information
NASA's Science Mission Directorate (SMD) - FAQ on Grants and Research during the COVID-19 Epidemic (March 31,2020)
NIAID NIAID's Multi-Pronged Response to the COVID-19 Outbreak
NSF  FAQs about COVID-19 for National Science Foundation Proporsers and Awardees  
New guidance for NSF awardees to implement flexibilities authorized by the Office of Management and Budget
Dear Colleague Letter
NSF Implementation of OMB Memorandum M-20-17   (March 23, 2020)
Dear Colleague Letter on COVID-19
FAQ's for Proposers and Awardee's About the Coronavirus Disease 2019 (COVID-19)
Coronavirus Updates and Funding Guidance 
existing funding opportunities
Guidance for Major Facilities and Contracts Regarding COVID-19
NIDCD  Eligibility Change to NOT-DC-20-004
Office of Management and Budget Memorandum to the Heads of Executive Departments and Agencies 
Patient-Centered Outcomes Research Institute (PCORI)  Introducing an Engagement Awards Funding Cycle to Address COVID-19 
 Substance Abuse and Mental Health Services Administration (SAMHSA) Information for SMAHSA Discretionary Grant Recipients 
 University of Utah / Office of Sponsored Projects COVID-19 Guidance for the Research Community 
Central Research Operations Guidance for Research Planning and Continuity
Research Community Updates
US Agency for International Development (USAID)  National Funding Announcement 
U.S. Army Medical Research and Development United States Arm Medical Research Acquisition Activity (USAMRAA) - COVID-19 website  
COVID-19 FAQs for Grant Applicants and Recipients (Version 1, March 16, 2020)
USAMRAA’s COVID-19 FAQs
COVID-19 FAQs for Grant Applicants and Recipients (Version 2, March 25, 2020)
DARPA Frequently Asked Question (FAQ) about COVID-19 (Coronavirus) for DARPA Performers
White House  Office of Science and Technology Policy  - COVID-19 High Performance Computing (HPC) Consortium 
Executive Order on Prioritizing and Allocating Health and Medical Resources to Respond to the Spread of COVID-19 (as of March 18, 2020).
Executive Order on Preventing Hoarding of Health and Medical Resources to Respond to the Spread of COVID-19 (as of March 23, 2020)
World Health Organization R&D Blueprint    - February 2020

 

 

Foundation/Private

Agency/Department

Title

Chan Zuckerberg Initiative (CZI) Chan Zuckerberg Initiative Coronavirus Response
InfoEd Global COVID-19/Coronavirus Resources 
READDI  Press Release 

 Back to top

 

Items of Interest 

Agency / Department  Title Date 
Home Grown  Home-Based Childcare Emergency Fund  Released on April 7th, 2020 

 Back to top